CASI Pharmaceuticals (CASI) Reports Q1 Loss of $0.06/Share

CASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• BofA lists top 5 themes driving next $1tn in incremental semi sales